Aspen Pharmacare Valuation
| APN Stock | 17,130 20.00 0.12% |
At this time, the firm appears to be overvalued. Aspen Pharmacare Holdings shows a prevailing Real Value of USD14046.6 per share. The current price of the firm is USD17130.0. Our model approximates the value of Aspen Pharmacare Holdings from analyzing the firm fundamentals such as Current Valuation of 78.78 B, return on equity of 0.095, and Profit Margin of 0.17 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Aspen Pharmacare's price fluctuation is very steady at this time. Calculation of the real value of Aspen Pharmacare Holdings is based on 3 months time horizon. Increasing Aspen Pharmacare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Aspen stock is determined by what a typical buyer is willing to pay for full or partial control of Aspen Pharmacare Holdings. Since Aspen Pharmacare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aspen Stock. However, Aspen Pharmacare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17130.0 | Real 14046.6 | Hype 17130.0 | Naive 16542.93 |
The real value of Aspen Stock, also known as its intrinsic value, is the underlying worth of Aspen Pharmacare Holdings Company, which is reflected in its stock price. It is based on Aspen Pharmacare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Aspen Pharmacare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Aspen Pharmacare Holdings helps investors to forecast how Aspen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aspen Pharmacare more accurately as focusing exclusively on Aspen Pharmacare's fundamentals will not take into account other important factors: Aspen Pharmacare Total Value Analysis
Aspen Pharmacare Holdings is presently forecasted to have takeover price of 78.78 B with market capitalization of 98.32 B, debt of 105 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Aspen Pharmacare fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
78.78 B | 98.32 B | 105 M |
Aspen Pharmacare Investor Information
About 19.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.88. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aspen Pharmacare Holdings recorded earning per share (EPS) of 14.32. The entity last dividend was issued on the 21st of September 2022. The firm had 407:400 split on the 6th of October 2008. Based on the measurements of operating efficiency obtained from Aspen Pharmacare's historical financial statements, Aspen Pharmacare Holdings is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Aspen Pharmacare Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aspen Pharmacare has an asset utilization ratio of 34.66 percent. This indicates that the Company is making USD0.35 for each dollar of assets. An increasing asset utilization means that Aspen Pharmacare Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Aspen Pharmacare Ownership Allocation
Aspen Pharmacare holds a total of 444.95 Million outstanding shares. Over half of Aspen Pharmacare's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Aspen Pharmacare. Please watch out for any change in the institutional holdings of Aspen Pharmacare Holdings as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Aspen Pharmacare Profitability Analysis
The company reported the revenue of 38.61 B. Net Income was 8.67 B with profit before overhead, payroll, taxes, and interest of 18.29 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Aspen Pharmacare's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Aspen Pharmacare and how it compares across the competition.
About Aspen Pharmacare Valuation
The stock valuation mechanism determines Aspen Pharmacare's current worth on a weekly basis. Our valuation model uses a comparative analysis of Aspen Pharmacare. We calculate exposure to Aspen Pharmacare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aspen Pharmacare's related companies.8 Steps to conduct Aspen Pharmacare's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Aspen Pharmacare's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Aspen Pharmacare's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Aspen Pharmacare's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Aspen Pharmacare's revenue streams: Identify Aspen Pharmacare's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Aspen Pharmacare's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Aspen Pharmacare's growth potential: Evaluate Aspen Pharmacare's management, business model, and growth potential.
- Determine Aspen Pharmacare's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Aspen Pharmacare's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Aspen Stock analysis
When running Aspen Pharmacare's price analysis, check to measure Aspen Pharmacare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspen Pharmacare is operating at the current time. Most of Aspen Pharmacare's value examination focuses on studying past and present price action to predict the probability of Aspen Pharmacare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspen Pharmacare's price. Additionally, you may evaluate how the addition of Aspen Pharmacare to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |